Fentanyl & Fentanyl Withdrawal

Host: Montana Primary Care Association

Friday, October 29, 2021 | 11:15 am - 12:15 pm MT

Live, In-Person Course | Helena, MT

Overview

This 1-hour, live in-person session as part of the Montana Primary Care Association's Addiction Medicine Network Meeting will provide a broad overview of the current fentanyl crisis and its impact on Addiction Treatment.

Fentanyl and fentanyl analogues are responsible for the majority of opioid related overdoses—both fatal and nonfatal.  Contamination with or replacement by fentanyl of heroin and other illicit drugs is now a problem across the United States. With increased use of fentanyl, newer and clinically important pharmacokinetic and pharmacodynamic information has been elucidated. This presentation will provide a broad overview of the current fentanyl crisis and its impact on Addiction Treatment.

The target audience for this introductory level activity includes: all health care providers

This activity addresses the following ACGME Competencies: Patient Care and Medical Based Knowledge. 

Learning Objectives

Upon completion, learners will be able to:

1. Describe the impact fentanyl has had on overdose deaths in the USA  
2. Understand  the synergistic effect of combining heroin plus fentanyl on overdose potential  
3. Explain the decreased effectiveness of Opioid Agonist Therapy when patients are using fentanyl.

Instructions

1. Click on the Contents tab to begin this activity. 
2. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window. 
3. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Gabapentinoids: A Wolf in Sheep's Clothing

Host: Montana Primary Care Association

October 29, 2021 | 3:15 pm - 4:15 pm MT

Live, In-Person Course | Helena, MT

Overview

This 1-hour, live in-person session as part of the Montana Primary Care Association's Addiction Medicine Network Meeting will provide a broad overview of the current state of gabapentanoid use and misuse.

Gabapentanoids are primarily prescribed for off-label indications. Although they are generally considered to be safe there are significant adverse effects when used therapeutically. Misuse of gabapentanoids is increasing, particularly in patients with an Opioid Use Disorder. Addiction medicine specialists often prescribe a gabapentanoid to avoid prescribing opioids and benzodiazepines. This presentation will provide a broad overview of the current state of gabapentanoid use and misuse.

The target audience for this introductory level activity includes: all health care providers

This activity addresses the following ACGME Competencies: Patient Care, Medical Based Knowledge. 

Learning Objectives

Upon completion, learners will be able to:

1. Understand the off-label use evidence for gabapentanoids.
2. Name the common adverse effects of gabapentanoids.
3. Describe the interaction between gabapentanoids and prescribed opioids.

Instructions

1. Click on the Contents tab to begin this activity. 
2. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window. 
3. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.